Literature DB >> 3072995

Transforming growth factors in the regulation of malignant cell growth and invasion.

J Keski-Oja1, A E Postlethwaite, H L Moses.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3072995     DOI: 10.3109/07357908809078038

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  8 in total

1.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

Authors:  D R Welch; A Fabra; M Nakajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  The mathematical modelling of tumour angiogenesis and invasion.

Authors:  M A Chaplain
Journal:  Acta Biotheor       Date:  1995-12       Impact factor: 1.774

4.  Transforming growth factor-beta activities in 'in vivo' lines of hormone-dependent and independent mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice.

Authors:  P V Elizalde; C Lanari; E Kordon; J Tezón; E H Charreau
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

5.  Autocrine and paracrine growth factors in tumor growth: a mathematical model.

Authors:  S Michelson; J Leith
Journal:  Bull Math Biol       Date:  1991       Impact factor: 1.758

6.  Distinct morphological and mito-inhibitory effects induced by TGF-beta 1, HGF and EGF on mouse, rat and human hepatocytes.

Authors:  B Petersen; C J Yee; W Bowen; R Zarnegar; G K Michalopoulos
Journal:  Cell Biol Toxicol       Date:  1994-08       Impact factor: 6.691

7.  Growth factors and growth control of heterogeneous cell populations.

Authors:  S Michelson; J T Leith
Journal:  Bull Math Biol       Date:  1993-09       Impact factor: 1.758

8.  A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours.

Authors:  M Franco; O D Bustuoabad; P D di Gianni; A Goldman; C D Pasqualini; R A Ruggiero
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.